Cost-effectiveness of a pentavalent human–bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan

References

• Parashar UD, Hummelman EG, Bresee JS. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003;9:565–72
   PubMed Web of Science ®Google Scholar
• Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002;21:221–7
   PubMed Web of Science ®Google Scholar
• Chen KT, Chen PY, Tang RB, et al. Sentinel hospital surveillance for rotavirus diarrhea in Taiwan, 2001–2003. J Infect Dis 2005;92(1 Suppl):S44–8
   Google Scholar
• Lu CY, Lauderdale TL, Fang YH, et al. Disease burden and related medical costs of rotavirus infections in Taiwan. BMC Infect Dis 2006;6:176
   PubMed Web of Science ®Google Scholar
• Wu CL, Yang YC, Huang LM. Cost-effectiveness of childhood rotavirus vaccination in Taiwan. Vaccine 2009;27:1492–9
   Google Scholar
• Centers for Disease Control. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2009;58:RR2
   Google Scholar
• Chang CC, Chang MH, Lin TY et al. Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan. J Formos Med Assoc 2009; 108:4; 280–5
   Google Scholar
• Mast TC, Chen PY, Lu KC, et al. Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and pediatric clinics in Taiwan, 2005–2006. Vaccine 2010;28:3008–13
   PubMed Web of Science ®Google Scholar
• National Health Insurance Annual Statistical Report: Taipei [in Chinese]. Bureau of National Health Insurance. Taiwan: Bureau of National Health Insurance, 2003
   Google Scholar
• Chen KT, Fan SF, Tang RB, et al. Hospital-based study of the economic burden associated with rotavirus diarrhea in Taiwan. Vaccine 2007;25:4266–72
   Google Scholar
• Podewils IJ, Antil L, Hummelman E, et al. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005;192(1 Suppl):S133–45
   Google Scholar
• Lorgelly PK, Joshi D, Iturriza Gomara M, et al. Exploring the cost-effectiveness of an immunization programme for rotavirus gastroenteritis in the UK. Epidemiol Infect 2007;136:1, 44–55
   PubMed Web of Science ®Google Scholar
• Newall AT, Beutels P, MaCartney K, et al. The cost-effectiveness of rotavirus vaccination in Australia. Vaccine 2007;25:8851–60
   PubMed Web of Science ®Google Scholar
• Rheingans RD, Constenla D, Antil L, et al. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in 8 Latin American and Caribbean countries. Rev Panam Salud Publica 2007;21:205–16
   PubMed Web of Science ®Google Scholar
• Widdowson MA, Meltzer MI, Zhang X, et al. Cost-effectiveness and potential impact of rotavirus vaccination in the US. Pediatrics 2007;119:684–97
   PubMed Web of Science ®Google Scholar
• Goossens LM, Standaert B, Hartwig N, et al. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands. Vaccine 2008;26:1118–27
   PubMed Web of Science ®Google Scholar
• Melliez H, Levybruhl D, Boelle PY, et al. Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine 2008;26:706–15
   PubMed Web of Science ®Google Scholar
• Ho AM, Nelson EA, Walker DG. Rotavirus vaccination for Hong Kong children: an economic evaluation from the Hong Kong government perspective. Arch Dis Child 2008;93:52–8
   Google Scholar
• Milne RJ, Grimwood K. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value in Health 2009;12:888–98
   PubMed Web of Science ®Google Scholar
• Jit M, Blicke J, Mangen MJ, et al. The cost-effectiveness of rotavirus vaccination: comparative analyses for 5 European countries and transferability in Europe. Vaccine 2009;27:6121–28
   PubMed Web of Science ®Google Scholar
• Lambert SB, Faux CE, Hall L, et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med S Aust 2009;191:157–60
   PubMed Web of Science ®Google Scholar
• Wang FT, Mast TC, Glass RJ, et al. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics 2010;125:e208–13
   PubMed Web of Science ®Google Scholar
• Zeller M, Rahman M, Heylen E, et al. Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium. Vacine 2010;28:7507–13
   PubMed Web of Science ®Google Scholar
• Buttery JP, Lambert SB, Grimwood K, et al. Reduction in rotavirus-associated acute gastroenteritis following the introduction of the rotavirus vaccine into Australia's national childhood vaccine schedule. Pediatr Inf Dis J 2011;30(1 Suppl):S25–9
   Web of Science ®Google Scholar
• Patel MM, Steele D, Gentsch JR, et al. Real world impact of rotavirus vaccination. Pediatr Inf Dis J 2011;30(1 Suppl):S1–5
   Web of Science ®Google Scholar
• Blicke J, Beutels P. Reviewing the cost-effectiveness of rotavirus vaccination. Pharmacoeconomics 2009;27:281–97
   PubMed Web of Science ®Google Scholar
• Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med 1996;335:1022–8
   PubMed Web of Science ®Google Scholar
• Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397–409
   PubMed Web of Science ®Google Scholar
• Velázquez FR, Calva JJ, Guerrero ML, et al. Cohort study of rotavirus serotype patterns in symptomatic and asymptomatic infections in Mexican children. Pediatr Infect Dis J 1993;12:54–61
   PubMed Web of Science ®Google Scholar
• Brisson M, Senecal M, Drolet M et al. Health-related quality of life lost to rotavirus-associated gastroenteritis in children and their parents: a Canadian prospective study. PIDJ 2010;29(1):73–75
   Google Scholar
• World Health Organization. The World Health Report. 2002. Reducing risks, promoting healthy life. Available at: http://www.who.int/whr/2002/en. Accessed 15 March 2011
   Google Scholar
• World Health Organization. Tables of costs and prices used in WHO-CHOICE analysis. 2007. World Health Organization Web site. Available at: www.who.int/choice/costs/CER_levels/en/index.html. Accessed 2 July 2009
   Google Scholar
• Dasbach EJ, Insinga RP, Yang YC, et al. The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan. Asian Pacific J of CancerPrev 2008;9:1–8
   PubMedGoogle Scholar
• International Monetary Fund. List of countries by GDP (nominal) per capita. Available at: http://en.wikipedia.org/wiki/List_of_countries_by_GDP_(nominal)_per_capita. Accessed 15 March 2011
   Google Scholar
• Statistical Yearbook of the Republic of China 2009. Table 151: Indices of Consumer Price by Commodity Quality. Available at: http://eng.stat.gov.tw/public/data/dgbas03/bs2/yearbook_eng/y151.pdf. Accessed March 28, 2011.
   Google Scholar
• IRS.gov. Yearly Average Exchange Rates for Converting Foreign Currencies into U.S. Dollars, 2010. Available at: http://www.irs.gov/businesses/small/international/article/0,,id=206089,00.html. Accessed 15 March 2011
   Google Scholar
• Current Immunization Schedule in Taiwan. Centers for Disease Control, ROC (Taiwan). Available at: http://www.cdc.gov.tw/lp.asp?ctNode=157&CtUnit=134&BaseDSD=7&mp=1. Accessed 29 December 2009
   Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Rotavirus efficacy and safety trial (REST) study team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23–33
   PubMed Web of Science ®Google Scholar
• Dennehy PH, Vesikari T, Matson DO. Efficacy of a pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series: potential benefits of early protection. Human Vaccines 2011;7:563–8
   PubMed Web of Science ®Google Scholar
• Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics 2010;125:e199–207
   PubMed Web of Science ®Google Scholar
• Payne D, Staat MA, Donauer S, et al. Postlicensure effectiveness of RotaTeq vaccine in US children. Abstract presented at: 5th International Conference on Vaccines for Enteric Diseases (VED); September 2009; Malaga, Spain
   Google Scholar
• Dennehy P, Goveia M, Dallas M, et al. The integrated Phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Int J Infect Dis 2007;11:36–42
   PubMed Web of Science ®Google Scholar
• Council of Labor Affairs, Government of Taiwan. Adjustment of the Basic Wage. Available at: http://www.cla.gov.tw/cgi-bin/siteMaker/SM_theme?page=48eaf6bd. Accessed 2 January 2010
   Google Scholar
• Griebsch I, Coast J, Brown J. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 2005;115:e600–8
   PubMed Web of Science ®Google Scholar
• Grange A, Bekker H, Noyes J, et al. Adequacy of health-related quality of life measures in children under 5 years old: systematic review. J Adv Nursing 2007;59:197–220
   PubMed Web of Science ®Google Scholar
• Statistical Yearbook of the Republic of China 2009. Table 18- Live Births by Age of Mother. Available at: http://eng.dgbas.gov.tw/public/data/dgbas03/bs2/yearbook_eng/y018.pdf. Accessed 28 March 2011
   Google Scholar